ADVB Temel İstatistikler
YÜKSEK
18.73
Açık
8.32
Hacim
23.66M
Düşük
8.08
Önceki Kapanış
7.08
İşlem Değeri
313.37M
52H En Yüksek
18.73
Göreceli Hacim
5.819
Dalgalanma (%)
150.42%
52H En Düşük
3.61
Devir Oranı
1432.14%
Piyasa Değeri
11.69M
F/K (TTM)
44.47
F/K (Yıllık)
--
GD/DD
1.27
F/S
--
Hisse Başına Kazanç (EPS)
0.159
Temettü (TTM)
0
Temettü Verimi
0.00%
Dolaşımdaki hisseler
1.65M
Para Birimi
USD
ADVB Fiyat Performansı
7 gün
30 gün
90 gün
180 gün
Yıl başından bugüne
1 Yıl
ADVB Para Akışı Dağılımı
ADVB Günlük Açığa Satış Hacmi
ADVB Short Interest Geçmişi
ADVB Hisse Özeti
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.445. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 54.02% above the daily low and 33.56% below the daily high, placing ADVB orta seviyesine yakın its most recent trading range.
Trading volume currently stands at 23.66M, compared with an average daily volume of 4.06M. This suggests that trading activity is olağan seviyesinin belirgin şekilde üzerinde than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 244.74% above its 52-week low and 33.56% below its 52-week high.
ADVB İlgili haberler
Hakkında ADVB
Şirket adı
Advanced Biomed Inc.
Sektör
Health Technology
Endüstri
Biotechnology
Borsalar
Nasdaq
Çalışan Sayısı
31
Lot Büyüklüğü
100
Resmî web sitesi
Para Birimi
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
